Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn about a paper by Elizabeth J. Schafer et al. published in Cancer Discovery:
“Interesting paper in Cancer Discovery!
Improvements in 5-year cause-specific survival and OS were greater in Medicaid expansion than non-expansion states among individuals residing in rural and high-poverty communities and among individuals diagnosed with cancers that generally have a worse prognosis, emphasizing the importance of Medicaid expansion in mitigating disparities in survival outcomes.”
Title: Association between Medicaid Expansion and 5-Year Survival among Individuals Diagnosed with Cancer
Authors: Elizabeth J. Schafer, Christopher J. Johnson, Fabio Y. Moraes, Xuesong Han, Jingxuan Zhao, Ahmedin Jemal
You can read the full article in Cancer Discovery.
More posts featuring Vivek Subbiah.